SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
Conditions: Lupus Nephritis; Chronic Kidney Diseases Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Standard maintenance therapy Sponsors: The University of Hong Kong Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chronic Kidney Disease | Dapagliflozin | Forxiga | Hong Kong Health | Lupus | Nephritis | Research | SGLT2 Inhibitors | Urology & Nephrology